Bryce

Do you get a sense of their rollouts as well?

And then you can compare the three based on their earnings reports as well?

I will add that in.

Nice.

The way I thought about that is just looking at US penetration because these guys operate in those markets.

And so I figured... But where are you going to get that number from?

Oh, I'd have to get it from Johnson & Johnson.

Yeah, yeah.

Because if you're just getting it, you're going to get the most rose-colored version if you're just looking at intuitive.

Yeah, yeah, yeah.

If I look at then how that has played out in the most recent quarter, looking at the metrics, so last quarter they reported in April revenue up 23%, total procedure growth of 17% and the da Vinci procedures up 16%, instrument and accessories revenue up 23% for the quarter to $1.7 billion.

Rollout of the DaVinci system has accelerated.

431 new systems placed in the quarter versus 367 a year ago.

232 of those were the new DaVinci V5.

They want everyone on the new one because it costs more, blah, blah, blah.

I mean, that accelerating growth rate of new machines is like, that's a great sign.

Great sign.

The installation, well, just total numbers has increased, as I said, up 12% year on year.

And their margins are increasing, operating margins are increasing as well, up 34%.

So against all the metrics that I was looking at, they are doing well.